More tools:Markets·Screener·Research·Chat

Abivax SA American Depositary Shares (ABVX) Financial Statements

Abivax SA American Depositary Shares
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG01JLQNZV9
XNAS · usd
118.95▲ 4.16 (3.62%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close114.79
Day's Range112.95 – 120.30
52-Week Range69.81 – 148.83
Volume1.6M
Avg Volume893.9K
Share Statistics
Shares Outstanding
Employees69
ExchangeXNAS
Listed2023-10-20
Share count as of December 31, 2025
Loading Income Statement…
Key questions about Abivax SA American Depositary Shares (ABVX)
What is Abivax SA American Depositary Shares's Market Cap?
Abivax SA American Depositary Shares's Market Cap is $9.3B, based on as-reported figures from SEC (XBRL) filings.
What is Abivax SA American Depositary Shares's Enterprise Value?
Abivax SA American Depositary Shares's Enterprise Value is $8.7B, based on as-reported figures from SEC (XBRL) filings.
What is Abivax SA American Depositary Shares's Net Income (TTM)?
Abivax SA American Depositary Shares's Net Income (TTM) is -$394.4M, based on as-reported figures from SEC (XBRL) filings.
What is Abivax SA American Depositary Shares's Diluted EPS (TTM)?
Abivax SA American Depositary Shares's Diluted EPS (TTM) is -5.02, based on as-reported figures from SEC (XBRL) filings.
What is Abivax SA American Depositary Shares's Net Debt?
Abivax SA American Depositary Shares's Net Debt is -$606.4M, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021
Profit or loss [abstract]
Other operating income
Total operating income
Sales and marketing
Research and development
General and administrative
Total operating expenses
Operating loss
Financial expenses
Financial income
Financial gain (loss)
Net loss before tax
Net loss for the period